Results suggest that blockade of SEMA4D signaling may serve to normalize astrocytic functions and slow astrocyte reactivity that is believed to contribute to pathology and symptoms of neurodegenerative disease. The gene discussed is SEMA4D; the disease is neurodegenerative disease.